These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 8405065)

  • 1. The effect of bone marrow and thymus chimerism between non-obese diabetic (NOD) and NOD-E transgenic mice, on the expression and prevention of diabetes.
    Parish NM; Chandler P; Quartey-Papafio R; Simpson E; Cooke A
    Eur J Immunol; 1993 Oct; 23(10):2667-75. PubMed ID: 8405065
    [TBL] [Abstract][Full Text] [Related]  

  • 2. E expression is needed on both bone marrow derived cells and thymic epithelium to increase IL-4 production and achieve protection in NOD bone marrow chimeras.
    Brenden N; Rietz C; Böhme J
    Cytokine; 1999 Oct; 11(10):766-72. PubMed ID: 10525315
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transplantation of bone marrow genetically engineered to express proinsulin II protects against autoimmune insulitis in NOD mice.
    Chan J; Clements W; Field J; Nasa Z; Lock P; Yap F; Toh BH; Alderuccio F
    J Gene Med; 2006 Nov; 8(11):1281-90. PubMed ID: 16989008
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mixed allogeneic chimerism induced by a sublethal approach prevents autoimmune diabetes and reverses insulitis in nonobese diabetic (NOD) mice.
    Li H; Kaufman CL; Boggs SS; Johnson PC; Patrene KD; Ildstad ST
    J Immunol; 1996 Jan; 156(1):380-8. PubMed ID: 8598488
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention of insulin-dependent diabetes mellitus in non-obese diabetic mice by transgenes encoding modified I-A beta-chain or normal I-E alpha-chain.
    Lund T; O'Reilly L; Hutchings P; Kanagawa O; Simpson E; Gravely R; Chandler P; Dyson J; Picard JK; Edwards A
    Nature; 1990 Jun; 345(6277):727-9. PubMed ID: 2163026
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevention of diabetes in non-obese diabetic I-Ak transgenic mice.
    Slattery RM; Kjer-Nielsen L; Allison J; Charlton B; Mandel TE; Miller JF
    Nature; 1990 Jun; 345(6277):724-6. PubMed ID: 1972779
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A peptide binding motif for I-Eg7, the MHC class II molecule that protects E alpha-transgenic nonobese diabetic mice from autoimmune diabetes.
    Gregori S; Trembleau S; Penna G; Gallazzi F; Hammer J; Papadopoulos GK; Adorini L
    J Immunol; 1999 Jun; 162(11):6630-40. PubMed ID: 10352280
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patterns of hemopoietic reconstitution in nonobese diabetic mice: dichotomy of allogeneic resistance versus competitive advantage of disease-resistant marrow.
    Kaufman CL; Li H; Ildstad ST
    J Immunol; 1997 Mar; 158(5):2435-42. PubMed ID: 9036994
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protection against autoimmune diabetes in mixed bone marrow chimeras: mechanisms involved.
    Mathieu C; Casteels K; Bouillon R; Waer M
    J Immunol; 1997 Feb; 158(3):1453-7. PubMed ID: 9013991
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Specific destruction of islet transplants in NOD<-->C57BL/6 and NOD<-->C3H/Tif embryo aggregation chimeras irrespective of allelic differences in beta-cell antigens.
    Leijon K; Hillörn V; Bergqvist I; Holmberg D
    J Autoimmun; 1995 Jun; 8(3):347-56. PubMed ID: 7575996
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention of autoimmune insulitis by expression of I-E molecules in NOD mice.
    Nishimoto H; Kikutani H; Yamamura K; Kishimoto T
    Nature; 1987 Jul 30-Aug 5; 328(6129):432-4. PubMed ID: 3302721
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Direct evidence for the contribution of the unique I-ANOD to the development of insulitis in non-obese diabetic mice.
    Miyazaki T; Uno M; Uehira M; Kikutani H; Kishimoto T; Kimoto M; Nishimoto H; Miyazaki J; Yamamura K
    Nature; 1990 Jun; 345(6277):722-4. PubMed ID: 2113614
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of diabetogenic T cells from NOD/Lt marrow is blocked when an allo-H-2 haplotype is expressed on cells of hemopoietic origin, but not on thymic epithelium.
    Serreze DV; Leiter EH
    J Immunol; 1991 Aug; 147(4):1222-9. PubMed ID: 1869820
    [TBL] [Abstract][Full Text] [Related]  

  • 14. I-Ag7-mediated antigen presentation by B lymphocytes is critical in overcoming a checkpoint in T cell tolerance to islet beta cells of nonobese diabetic mice.
    Noorchashm H; Lieu YK; Noorchashm N; Rostami SY; Greeley SA; Schlachterman A; Song HK; Noto LE; Jevnikar AM; Barker CF; Naji A
    J Immunol; 1999 Jul; 163(2):743-50. PubMed ID: 10395666
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An explanation for the protective effect of the MHC class II I-E molecule in murine diabetes.
    Reich EP; Sherwin RS; Kanagawa O; Janeway CA
    Nature; 1989 Sep; 341(6240):326-8. PubMed ID: 2507922
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of insulitis and diabetes in B cell-deficient NOD mice.
    Yang M; Charlton B; Gautam AM
    J Autoimmun; 1997 Jun; 10(3):257-60. PubMed ID: 9218752
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic and immunological basis of autoimmune diabetes in the NOD mouse.
    Yoshida K; Kikutani H
    Rev Immunogenet; 2000; 2(1):140-6. PubMed ID: 11324686
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lazaroid antioxidant reduces incidence of diabetes and insulitis in nonobese diabetic mice.
    Rabinovitch A; Suarez WL; Power RF
    J Lab Clin Med; 1993 Apr; 121(4):603-7. PubMed ID: 8454942
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alleviation of insulitis in NOD mice is associated with expression of transgenic MHC E molecules on primary antigen-presenting cells.
    Pilström B; Böhme J
    Immunology; 1997 Apr; 90(4):483-8. PubMed ID: 9176099
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IL-4 prevents insulitis and insulin-dependent diabetes mellitus in nonobese diabetic mice by potentiation of regulatory T helper-2 cell function.
    Cameron MJ; Arreaza GA; Zucker P; Chensue SW; Strieter RM; Chakrabarti S; Delovitch TL
    J Immunol; 1997 Nov; 159(10):4686-92. PubMed ID: 9366391
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.